REGENETEN™ Bioinductive Implant System in Full-thickness Tears
(REGENETEN Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing a shoulder tendon repair surgery with an extra treatment called REGENETEN. It targets patients with large or massive shoulder tears. REGENETEN helps by providing a structure for new tissue to grow, aiding the healing process. REGENETEN is a bioinductive type-1 collagen implant used to repair partial-thickness rotator cuff tears without formal tendon-bone reattachment.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have used oral or injected steroids in the last 4 weeks, you may not be eligible to participate.
What data supports the effectiveness of the treatment Arthroscopic rotator cuff repair with the REGENETEN™ Bioinductive Implant System?
Research shows that using the REGENETEN bio-inductive collagen implant in rotator cuff repair can increase tendon thickness and improve healing rates, reducing the chances of the tear happening again. Studies also indicate that this implant can enhance clinical outcomes for patients with full-thickness rotator cuff tears.12345
Is the REGENETEN Bioinductive Implant safe for humans?
How is the REGENETEN Bioinductive Implant treatment different from other treatments for rotator cuff repair?
The REGENETEN Bioinductive Implant is unique because it uses a bio-inductive collagen implant to promote new tissue growth and increase tendon thickness, which can help improve healing in rotator cuff repairs. Unlike other treatments that may provide immediate structural support, this implant focuses on enhancing the body's natural healing process over time.23578
Research Team
Chris Peach, MBBS MD FRCS (Tr&Orth)
Principal Investigator
Manchester University NHS Foundation Trust
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Arthroscopic rotator cuff repair (ARCR) with or without REGENETEN™ Bioinductive Implant
Initial Follow-up
Participants are monitored post-surgery at 2 weeks and 6 weeks for initial recovery and assessment
Extended Follow-up
Participants are monitored for safety and effectiveness at 3, 6, 12, and 24 months post-surgery
Treatment Details
Interventions
- Arthroscopic rotator cuff repair
- Arthroscopic rotator cuff repair for revision surgery
- REGENETEN™ Bioinductive Implant System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Smith & Nephew, Inc.
Lead Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley